Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan

Journal of Hepatology

Volumn 27, Issue 2, 1997, Pages 320-330

  Yu, Ming Whei ^a   Lien, Ju Ping ^a   Chiu, Yueh Hsya ^a   Santella, Regina M ^b   Liaw, Yun Fan ^c   Chen, Chien Jen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

AFB1 albumin adduct; Chronic hepatitis B virus carriers; Glutathione S transferase M1; Hepatocellular carcinoma; Urinary aflatoxin metabolites

Indexed keywords

AFLATOXIN; AFLATOXIN B1; CARCINOGEN;

ADULT; ARTICLE; CANCER RISK; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ADDUCT; HEPATITIS B; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; VIRUS CARCINOGENESIS; VIRUS CARRIER;

EID: 0001205434     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80178-X     Document Type: Article

References (46)

1. Yu MW, Tsai SF, Hsu KH, You SL, Lee SS, Lin TM, et al. Epidemiologic characteristics of malignant neoplasms in Taiwan. II. Liver cancer. J Natl Public Health Assoc (ROC). 8:1988;125-138.
2. Yu MW, You SL, Chang AS, Lu SM, Liaw YF, Chen CJ. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res. 51:1991;5621-5625.
3. Chen CJ, Liang KY, Chang AS, Chang YC, Lu SN, Liaw YF, et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology. 13:1991;398-406.
4. Chen CJ, Yu MW, Wang CJ, Huang HY, Lin WC. Multiple risk factors of hepatocellular carcinoma: a cohort study of 13737 male adults in Taiwan. J Gastroenterol Hepatol. 8:1993;s83-s87. (suppl).
5. Yu MW, Chen CJ, Luo JC, Brandt-Rauf PW, Carney WP, Santella RM. Correlations of chronic hepatitis B virus infection and cigarete smoking with elevated expression of neu oncoprotein in the development of hepatocellular carcinoma. Cancer Res. 54:1994;5106-5110.
6. Yu MW, Hsieh HH, Pan WH, Yang CS, Chen CJ. Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma. Cancer Res. 55:1995;1301-1305.
7. Yu MW, Chen CJ. Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Res. 53:1993;790-794.
8. Yu MW, Gladek-Yarborough A, Chiamprasert S, Santella RM, Liaw YF, Chen CJ. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology. 109:1995;1266-1273.
9. Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol. 17:1994;71-91.
10. Dragan YP, Pitot HC. Aflatoxin carcinogenesis in the context of the multistage nature of cancer. Eaton DL, Groopman JD. The Toxicology of Aflatoxins. 1994;179-198 Academic Press, New York.
11. Van Rensburg SJ, Cook-Mozaffari P, Van Schalkwyk DJ, Van Der Watt JJ, Vincent TJ, Purchase IF. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br J Cancer. 51:1985;713-726.
12. Yeh FS, Yu MC, Mo CC, Luo S, Tong MJ, Henderson BE. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res. 49:1989;2506-2509.
13. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:1994;4855-4878.
14. Aguilar F, Harris CC, Sun T, Hollstein M, Cerutti P. Geographic variation of p53 mutational profile in nonmalignant human liver. Science. 264:1994;1317-1319.
15. 1 induces the transversion of G→T in codon249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci USA. 90:1993;8586-8590.
16. Lam KC, Yu MC, Leung JWC, Henderson BE. Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong. Cancer Res. 42:1982;5246-5248.
17. Lu SN, Lin TM, Chen CJ, Chen JS, Liaw YF, Chang WY, et al. A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer. 62:1988;2051-2055.
18. 1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma. Hepatology. 16:1992;1150-1155.
19. Groopman JD, Jiaqi Z, Donahue PR, Pikul A, Lisheng Z, Chen JS, et al. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi autonomous region, People's Republic of China. Cancer Res. 52:1992;45-52.
20. Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev. 3:1994;3-10.
21. Wild CP, Hudson GJ, Sabbioni G, Chapot B, Hall AJ, Wogan GN, et al. Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Cancer Epidemiol Biomarkers Prev. 1:1992;229-234.
22. 1-DNA adducts. Cancer Epidemiol Biomarkers Prev. 5:1996;613-619.
23. Chen CJ, Wang LY, Lu SN, Wu MH, You SL, Zhang YJ, et al. Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology. 24:1996;38-42.
24. Wang LY, Hatch M, Chen CJ, Levin B, You SL, Lu SN, et al. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int J Cancer. 67:1996;620-625.
25. Chen CJ, Yu MW, Liaw YF, Wang LW, Chiamprasert S, Matin F, et al. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am J Hum Genet. 59:1996;128-134.
26. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst. 85:1993;1159-1164.
27. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 124:1986;17-27.
28. Eaton DL, Ramsdell HS, Neal GE. Biotransformation of aflatoxins. Eaton DL, Groopman JD. The Toxicology of Aflatoxins. 1994;45-72 Academic Press, New York.
29. 1 in the monkey, rat, and mouse. Toxicol Appl Pharmacol. 55:1980;115-125.
30. 7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases. Cancer Res. 46:1986;3924-3931.
31. 1-DNA adduct formed in vivo in rat liver. Proc Natl Acad Sci USA. 75:1978;1745-1749.
32. 1-treated rats. Cancer Res. 41:1981;650-654.
33. 1 modified deoxyribonucleic acid in vitro. Biochemistry. 19:1980;1692-1698.
34. 1-DNA adducts in human fibroblasts. Cancer Res. 41:1981;5125-5129.
35. Imaoka S, Sugiyama T, Taniguchi N, Funae Y. Expression of cytochrome P450 in LEC rats during the development of hereditary hepatitis and hepatoma. Carcinogenesis. 14:1993;117-121.
36. 1 by human liver tissue from Thailand. Am Assoc Cancer Res. 34:1993;162.
37. 1 in rat liver. J Natl Cancer Inst. 47:1971;585-592.
38. Coulombe RA, Shelton DW, Sinnhuber RO, Nixon JE. Comparative mutagenicity of aflatoxins using a Salmonella/trout hepatic enzyme activation system. Carcinogenesis. 3:1982;1261-1264.
39. 1 in the rat. Food Chem Toxicol. 22:1984;1027-1028.
40. 1 carcinogenesis: comparative kinetics of microsomal biotransformation. Cancer Res. 50:1990;615-620.
41. 1. Cancer Res. 54:1994;101-108.
42. Guengerich FP, Turvy CG. Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J Pharmacol Exp Ther. 256:1991;1189-1194.
43. Eaton DL, Gallagher EP. Mechanisms of aflatoxin carcinogenesis. Annu Rev Pharmacol Toxicol. 34:1994;135-172.
44. Lin HJ, Han CY, Bernstein DA, Hsiao W, Lin BK, Hardy S. Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application of bladder cancer susceptibility. Carcinogenesis. 15:1994;1077-1081.
45. Liu YH, Taylor J, Linko P, Lucier GW, Thompson CL. Glutathione S-transferase μ in human lymphocyte and liver: role in modulating formation of carcinogen-derived DNA adducts. Carcinogenesis. 12:1991;2269-2275.
46. 1 binding to DNA in woodchuck hepatocytes. Cancer. 73:1994;596-604.